Alexza Announces the Adasuve (Staccato Loxapine) PDAC Meeting Date of December 12, 2011
MOUNTAIN VIEW, Calif., Oct. 24, 2011 /PRNewswire/ -- Alexza
Pharmaceuticals, Inc. announced today that the U.S.
Food Drug Administration (FDA) has scheduled a meeting of the
Psychopharmacologic Drugs Advisory Committee (PDAC) for December
12,... (Source: Drugs.com - New Drug Applications)
Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato Loxapine) NDA
MOUNTAIN VIEW, Calif.,
Jan. 18, 2011 /PRNewswire/ -- Alexza
Pharmaceuticals, Inc. announced today that it
completed an End-of-Review meeting with the U.S. Food and Drug
Administration (FDA or Agency) for the AZ-004 New Drug Application
(NDA),... (Source: Drugs.com - New Drug Applications)